Techno Medica Co., Ltd.

Business Details

The company's core business is the research and development, manufacturing, and sale of clinical testing analyzers and medical devices. Products are classified into three categories: (1) Blood Collection Tube Preparation Equipment & Systems, (2) Specimen Testing Equipment, and (3) Consumables, etc. Blood Collection Tube Preparation Equipment is the flagship product for medical institutions in Japan and overseas, while Consumables form a stable revenue base that grows with the increasing number of installed units. The company employs a fab-light model that concentrates management resources on R&D and sales.

Recent Overview

In FY2026 (ending March 2026), sales increased 13.4% and operating profit increased 28.3%, driven by contributions from large-scale Blood Collection Tube Preparation Equipment projects

For the full year of FY2026 (ending March 2026), the company achieved sales of ¥11,236 million (up 13.4% year on year), operating profit of ¥1,668 million (up 28.3% year on year), and ordinary profit of ¥1,717 million (up 31.8% year on year). Blood Collection Tube Preparation Equipment & Systems drove results, growing 34.5% year on year on the back of steady progress in large-scale domestic facility projects. On the other hand, due to the discontinuation of manufacturing for certain models of Blood Collection Tube Preparation Equipment, the company recorded a provision for loss on discontinuation of manufacturing of ¥192,500 thousand as an extraordinary loss, limiting net income to ¥1,070 million (up 6.6% year on year). The annual dividend was significantly increased to ¥129 (from ¥68 in the prior period). For FY2027 (ending March 2027), the company forecasts sales of ¥10,300 million and operating profit of ¥1,100 million, representing a decline in both sales and profit, reflecting more cautious capital investment by medical institutions.

Key Products

Growth Drivers

• Continued orders for large-scale domestic facility projects for Blood Collection Tube Preparation Equipment & Systems (achieved a 37.3% year-on-year increase in FY2026, ending March 2026)
• Continued stable demand for Consumables, etc. (structural growth accompanying the increase in installed equipment units, up 3.0% year on year in FY2026, ending March 2026)
• Expansion in overseas markets (growth of compact-type Blood Collection Tube Preparation Equipment in the Asian market, with an overseas sales ratio of 12.8%)
• Increasing demand for Blood Collection Tube Preparation Equipment & Systems driven by task-shifting in medical settings and growing needs for operational efficiency and DX promotion
• Promotion of solution proposals centered on the flagship model BC・ROBO-9000RFID
• Market expansion beyond medical institutions through the development and sale of Self-Monitoring Products

Risks

• Large-scale projects for Blood Collection Tube Preparation Equipment & Systems are prone to timing shifts (advances or delays) in sales, resulting in high risk of period-to-period sales volatility (an 8.3% year-on-year decrease in sales is forecast for FY2027, ending March 2027)
• Risk that rising raw material and utility costs will push up the cost ratio of Consumables, etc., pressuring profit margins
• Risk that the business environment for medical institutions will deteriorate due to healthcare cost containment policies and medical fee schedule revisions, leading to more selective and cautious capital investment
• Risk of costs arising from product portfolio reviews, such as the extraordinary loss recorded due to the discontinuation of manufacturing for certain models of Blood Collection Tube Preparation Equipment (a provision for loss on discontinuation of manufacturing of ¥192,500 thousand was recorded in FY2026, ending March 2026)
• Risk of declining profit contribution due to intensifying competition in domestic Specimen Testing Equipment (domestic Specimen Testing Equipment sales declined 24.7% year on year in FY2026, ending March 2026)
• Risk of increased SG&A expenses due to rising personnel costs (wage increases)